Multiple metallic stents placement for malignant hilar biliary obstruction: Perspective of a radiologist

Abstract

In the palliative setting, the necessity of biliary drainage of both liver lobes for malignant hilar biliary obstruction remains controversial. However, bilateral biliary drainage is a reasonable option to prevent cholangitis of the undrained lobe and to preserve liver function during the course of chemotherapy. Bilateral biliary drainage can be accomplished by the percutaneous or endoscopic placement of multiple self-expandable metallic stents (SEMS). Although SEMS placement via bilateral (multiple) percutaneous routes is technically simple, multiple percutaneous transhepatic biliary drainage (PTBD) may lead to additional morbidity. SEMS placement via a single percutaneous route is a useful method; however, negotiation of a guidewire into the contralateral bile duct is occasionally impossible if the hilar angle between the right hepatic duct and left hepatic duct is acute. Percutaneous dual SEMS placement is generally performed using the stent-in-stent technique (T configuration or Y configuration) or the side-by-side technique. In addition, the crisscross technique has been reported as being a useful method for trisegmental drainage. The side-to-end technique is also useful for multiple SEMS placement. In the future, the combination of percutaneous intervention and endoscopic ultrasonography-guided procedures may be effective in the management of malignant hilar biliary obstruction.

Keywords: Biliary tract neoplasms, Drainage, Self-expandable metallic stents

Introduction

Biliary obstruction due to hepatic hilar malignancy, including advanced Klatskin tumors, is difficult to treat because of complicated anatomical factors.1 Because most patients with hepatic hilar malignancy are not good candidates for curative resection, palliative biliary decompression is achieved through biliary-enteric bypass surgery, endoscopic drainage, and percutaneous transhepatic biliary drainage (PTBD).2–4 Endoscopic drainage is the primary treatment for patients with biliary obstruction. However, there are some patients in whom bile duct access is not possible because of failed biliary cannulation or an inaccessible papilla. In these patients, PTBD is performed as an effective biliary drainage method.5

Percutaneous or endoscopic placement of a metallic stent is a well-established palliative treatment for advanced hilar malignancy.6–13 Although there have been many studies on the outcome of unilateral and bilateral stent placement in patients with advanced hilar malignancy according to the Bismuth-Corlette classification,11–17 there is no definitive consensus on the best stent placement method. The decision on whether to perform unilateral or bilateral stent placement depends on the extent of the malignant biliary stricture and on the degree of biliary tract contamination.18

Unilateral drainage via a single percutaneous route carries a lower risk of complications associated with PTBD, and it is well known that the biliary drainage of > 25% of the liver volume is required for adequate palliation of obstructive cholestasis and to improve biochemical parameters.19,20 Therefore, unilateral stent placement into one functional liver lobe may provide adequate palliation in most patients with malignant hilar biliary obstruction.16–21

In contrast, in some patients, bilateral stent placement may be the best option for palliative drainage when bilateral biliary ducts are contaminated or if chemotherapy is scheduled.12,22 Recently, an analysis of the factors predicting drainage effectiveness during endoscopic stent placement for malignant hilar biliary strictures was reported.18 The main factor associated with effective drainage was the volume of the liver drained (> 50%), as assessed using computed tomography (CT). Moreover, > 50% drainage was associated with prolonged survival in treated patients compared with patients with < 50% drainage. Therefore, to achieve a drainage volume of > 50% and its associated benefits, bilateral or multiple drainages may be warranted.

Various self-expandable metallic stents (SEMS), such as the open-cell design stent, are available for the treatment of malignant biliary obstruction. In addition, several techniques of multiple stent placement for bilateral drainage have been developed to improve the success rate and prevent complications associated with percutaneous biliary procedures.22–27

As described above, in the palliative setting, the necessity of biliary drainage of both liver lobes for malignant hilar biliary obstruction is still controversial. However, bilateral biliary drainage is a reasonable option to prevent cholangitis of the undrained lobe and to preserve liver function during the course of chemotherapy. Bilateral biliary drainage can be accomplished by the percutaneous placement of multiple SEMS.7–12,18,22–27

This review discusses the technique for the percutaneous placement of multiple SEMS, reintervention for stent occlusion, and possible future developments.

Percutaneous Transhepatic Biliary Drainage

Before PTBD, high-quality imaging, such as multidetector CT (MDCT) or magnetic resonance cholangiopancreatography, is essential in the workup of the patient to assess the anatomy and plan the most appropriate access route for PTBD.27–31 MDCT is also useful for evaluating complications, such as ascites and gastrointestinal obstruction, caused by tumor dissemination.

Significant amounts of ascites separating the liver from the abdominal wall should be drained prior to biliary intervention as this increases the risk of hemorrhage and catheter displacement into the peritoneum.29

Coagulopathy (international normalized ratio ≥ 1.5 and platelet count ≤ 50,000/mm³) is a relative contraindication to percutaneous transhepatic cholangiography and biliary drainage.30 Every effort should be made to correct or improve coagulopathy before the procedure.32

The technique of PTBD is well established.22–30 The PTBD procedure is performed under conscious sedation using intravenous premedication, such as pentazocine hydrochloride, and local anesthesia, such as lidocaine hydrochloride. Under the guidance of ultrasonography (US) or fluoroscopy, the peripheral intrahepatic bile duct is punctured with an 18-gauge needle in a one-step technique or a 21-gauge needle in a two-step technique, and a 7 to 10 Fr drainage catheter is inserted to relieve jaundice or cholangitis before insertion of the stent. Intravenous antibiotics are administered before the procedure and on the day after the procedure.30,33

SEMS placement is generally performed within 1 to 2 weeks after PTBD and relieves jaundice or holangitis.8,13,22

Access Route

Bilateral (multiple) percutaneous routes

Bilateral (multiple) percutaneous routes allow for easy handling and negotiation of a guidewire into the common bile duct (CBD) through the stricture caused by the tumor. SEMS placement via bilateral access is also technically simple. However, multiple PTBD procedures may lead to additional morbidity and discomfort from multiple drainage tubes.8,28

Single percutaneous route

SEMS placement via a single percutaneous route using the stent-in-stent technique has been reported as being a useful method in several articles along with reports on the development of various open-cell design stents.22,24,26,27 There are several anatomical variants of the right posterior duct (RPD) jointing the right hepatic duct (RHD) or the left hepatic duct (LHD). In addition, the angle between the RPD and the jointing duct is often acute.10 Hence, in a patient with hilar tumor extending beyond the segmental ducts, the left-sided percutaneous route may be better in multiple SEMS placements for trisegmental drainage via a single percutaneous route. When inserting a guidewire into the contralateral bile duct through the hilar stricture, a “safety-wire” technique using an 8 to 10 Fr sheath is useful.29 The seeking biliary catheter is inserted alongside a safety wire, which is inserted into the CBD, and another guidewire is inserted via the catheter to select the contralateral bile duct.

However, negotiation of a guidewire into the contralateral bile duct is occasionally impossible if the hilar angle between the RHD and LHD is acute.22,26 In such cases, an additional contralateral route is needed.

Additional route

In patients with surgical biliary reconstruction, malignant biliary obstruction may be difficult to treat, especially by an endoscopic route, because of complicated anatomical changes after operative reconstruction.34 Furthermore, afferent limb obstruction sometimes occurs with biliary obstruction. Although PTBD is an effective treatment for these conditions, it may introduce the risk of retrograde biliary infection. An additional percutaneous jejunostomy route may be useful for biliary obstruction complicated with afferent limb obstruction (Fig. 1).34 However, percutaneous jejunostomy carries a risk of intraperitoneal digestive fluid leakage from the afferent limb.35

Figure 1

Afferent limb syndrome caused by tumor recurrence of bile duct cancer after biliary reconstruction. (A, B) Enhanced computed tomography shows dilation of the afferent limb and intrahepatic biliary duct caused ...

Metallic Stent Placement Technique

Side-by-side technique

The side-by-side technique is the placement of two parallel metallic stents to drain the bile ducts of both liver lobes (Fig. 2).12,37 Although this placement technique is simple, bilateral percutaneous routes are needed. In addition, this parallel placement may overstretch the CBD and prevent full expansion of metallic stents at the hepatic confluence.22,24

Figure 2

(A, B) Biliary obstruction caused by hilar liver metastasis of lung cancer. Two bare stents were placed in a parallel fashion via bilateral routes (8-mm diameter, 60-mm length, two EGIS ...

Stent-in-stent technique

In the stent-in-stent technique, a second stent is placed through the mesh of the first stent to enter the CBD.22,26,27,37 By using this technique, the entire length of the stricture can continuously expand within a single stent caliber.22 Moreover, the overlapping of two stents can effectively prevent the displacement of stents.8,24 However, passing the second stent through the mesh of the first stent can be technically difficult if the first stent has a tightly woven closed-cell design.22

Two-stent placement in a T configuration via a single route is suitable for an obtuse hilar angle between the RHD and LHD.22,26 Stent placement in a T configuration is performed either via the right or left access. The transverse stent is placed first to connect the right and left lobar ducts, and a guidewire is inserted from an access route into the CBD through the mesh of the first stent. The second stent, connecting the transverse stent to the CBD, is then placed (Fig. 3).26

Figure 3

Hilar invasion of gall bladder cancer. (A) The cholangiogram shows hilar biliary obstruction. (B) The first stent (8-mm diameter, 40-mm length, Zilver stent; COOK Medical) was placed from the left ...

For an acute hilar angle, two-stent placement in a Y configuration via bilateral routes is technically easy.22,26 In Y-configured stent placement, the first stent is placed connecting one lobar duct and the CBD. Then, a guidewire is inserted from the contralateral route into the CBD through the mesh of the first stent. The second stent, connecting another lobe to the CBD, is then placed (Fig. 4).26

Figure 4

Hilar dissemination of gastric cancer. (A) The cholangiogram via bilateral routes shows hilar biliary obstruction. (B, C) The first stent (8-mm diameter, 60-mm length, Zilver stent; COOK Medical) was placed ...

For a lesion that separates the right anterior duct from the RPD, two-stent placement in a crisscross configuration is a useful technique.10 Crisscross-configured stent placement is performed with two stents inserted via two unilateral or bilateral accesses. The first stent is placed connecting a right segment duct and the LHD. The second stent is then placed from another right segment duct crossing the first stent to the CBD (Fig. 5).10

Figure 5

Hilar cholangiocarcinoma. (A) The cholangiogram shows hilar biliary obstruction with separation between each segment duct (right anterior duct [RAD], right posterior duct [RPD], and left hepatic duct [LHD]). Residual fractured ...

Side-to-end technique

In the side-to-end technique, a second stent is placed overlapping with the proximal edge of the first stent.38 By using this technique, there is no need to pass a second metallic stent delivery system through the mesh of the first stent. However, if stent placement via a single route is performed using this technique, parallel insertion of a two-stent delivery system is needed (Fig. 6). Therefore, dilation of the access route is required.

Figure 6

Hilar liver metastasis of pancreatic cancer. (A) The cholangiogram shows hilar biliary obstruction with separation between each segment duct (right anterior duct [RAD], right posterior duct [RPD], and left hepatic ...

Although the entire length of the stricture can expand within a single stent caliber, the risk of separation between the first stent and second stent should be considered (Fig. 7). Hence, the favorable feature of SEMS in this technique is minimal foreshortening during deployment.

Figure 7

Enhanced computed tomography shows the separation between the first stent and the second stent (arrow).

Complications

There are some complications associated with percutaneous biliary procedures. These include sepsis, hemobilia, and infections, such as peritonitis, cholecystitis, pancreatitis, and pleuritis.32,33 However, most complications are related to the initial PTBD and are usually self-limiting.12,32,39 The use of prophylactic periprocedural antibiotics can help to reduce the incidence of procedure-associated infections.30,32 Although a temporary drainage catheter is placed after stent placement, bile leakage around the clamped catheter usually indicates stent occlusion and should be investigated by cholangiography.33 Crushing of the first stent during insertion of the second stent has been reported as a complication of the stent-in-stent technique.26

Reintervention

Stent occlusion is caused by tumor ingrowth, biliary sludge, and mucosal hyperplasia by chronic inflammation.37 Although current approaches include a second SEMS placement, PTBD, and mechanical cleaning, the appropriate management for stent occlusion has not been well established.40 Unfortunately, mechanical cleaning has been proven to be ineffective because it provides suboptimal patency time.41

The outcome of second interventions, including plastic stent (PS), SEMS, and PTBD, for occluded SEMS in patients with malignant biliary obstruction, has been investigated.40 According to that report, in general, a second SEMS insertion in occluded SEMS provided a significantly longer patency time compared with PS or PTBD. However, in hilar obstruction, there was no statistical difference in patency and survival time. Hence, the benefit of a second SEMS placement in poor-prognosis patients with hilar biliary obstruction remains controversial.

Future Developments

In recent years, endoscopic ultrasonography (EUS)-guided procedures have been developed.5,42 However, EUS-guided choledocoduodenostomy is not indicated for hilar biliary obstruction. In addition, EUS-guided hepaticogastrostomy may be not suitable for hilar biliary obstruction because inserting a guidewire from the LHD into the RHD through the hilar stricture is technically difficult.5

The combination of percutaneous stent placement connecting both lobar ducts and EUS-guided hepaticogastrostomy can be effective in the management of malignant hilar biliary obstruction (Fig. 8). Furthermore, in the EUS-guided procedure, a second intervention for stent occlusion requires substantial technique, such as additional stent placement or stent exchange. If a second intervention via the endoscopic route is unsuccessful, percutaneous procedures are useful (Fig. 9). These EUS-guided procedures should be performed in institutions with back-up procedure systems, such as PTBD or surgery, for unsuccessful EUS-guided procedures.

Figure 8

Hilar invasion of gall bladder cancer after endoscopic ultrasonography-guided hepaticogastrostomy. (A) The cholangiogram via the right anterior duct (RAD) shows hilar biliary obstruction. (B, C) A guidewire was inserted from ...

Figure 9

Stent occlusion after endoscopic ultrasonography-guided hepaticogastrostomy for pancreatic cancer. (A) The endoscopic cholangiogram shows stent occlusion caused by mucosal hyperplasia. However, the stent delivery system could not pass the stricture ...

Recently, endoscopic photodynamic therapy and radiofrequency ablation in combination with biliary stenting for pancreatobiliary cancers have been used to improve stent patency.43,44 In addition, the feasibility studies of percutanenous intraductal device, though few in number, have been reported.45,46 Mizandari et al46 indicated that percutaneous intraductal radiofrequency ablation combined with biliary stenting was feasible and safe for malignant biliary obstruction including cholangiocarcinoma.

Drug eluting stents have a local cytotoxic effect in malignant disease and may delay the time to reocclusion.29 To date, there are a few published studies on the use of drug-eluting stents for malignant biliary obstruction.47

Although these developing treatments may be promising, there are no sufficient data of patients with malignant hilar biliary obstruction. Hence, further investigation such as randomized, prospective studies is necessary.

Conclusion

Percutaneous multiple SEMS placement is a feasible palliative treatment in patients with hepatic hilar malignancy. However, adequate levels of experience and technique are required. In addition, accurate anatomical assessment and planning of the most appropriate access route for PTBD and subsequent SEMS placement are essential.

Acknowledgments

This material was presented at the Society of Gastrointestinal Intervention Meeting 2015.

Article information

Gastrointestinal Intervention.Mar 31, 2016; 5(1): 52-59.

Published online 2016-03-31. doi: 10.18528/gii150027

Yozo Sato, Yoshitaka Inaba, Kazuo Hara, Hidekazu Yamaura, Mina Kato, Shinichi Murata, Yui Onoda

¹Department of Diagnostic and Interventional Radiology, Aichi Cancer Center Hospital, Nagoya, Japan

²Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan

^*Corresponding author. Department of Diagnostic and Interventional Radiology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya 464-8681, Japan. E-mail address:ysato@aichi-cc.jp (Y. Sato).

Received October 8, 2015; Accepted November 17, 2015.

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Articles from Gastrointestinal Intervention are provided here courtesy of Gastrointestinal Intervention

References

Catalano OA, Singh AH, Uppot RN, Hahn PF, Ferrone CR, Sahani DV. Vascular and biliary variants in the liver: implications for liver surgery. Radiographics. 2008;28:359-78.
Kim JH. Endoscopic stent placement in the palliation of malignant biliary obstruction. Clin Endosc. 2011;44:76-86.
Raijman I. Biliary and pancreatic stents. Gastrointest Endosc Clin N Am. 2003;13:561-92.
Wagner HJ, Knyrim K, Vakil N, Klose KJ. Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and randomized trial. Endoscopy. 1993;25:213-8.
Ikeuchi N, Itoi T. Endoscopic ultrasonography-guided biliary drainage: an alternative to percutaneous transhepatic puncture. Gatrointest Interv. 2015;4:31-9.
De Palma GD, Pezzullo A, Rega M, Persico M, Patrone F, Mastantuono L. Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study. Gastrointest Endosc. 2003;58:50-3.
Kawamoto H, Tsutsumi K, Harada R, Fujii M, Kato H, Hirao K. Endoscopic deployment of multiple JOSTENT SelfX is effective and safe in treatment of malignant hilar biliary strictures. Clin Gastroenterol Hepatol. 2008;6:401-8.
Kim CW, Park AW, Won JW, Kim S, Lee JW, Lee SH. T-configured dual stent placement in malignant biliary hilar duct obstructions with a newly designed stent. J Vasc Interv Radiol. 2004;15:713-7.
Kim JY, Kang DH, Kim HW, Choi CW, Kim ID, Hwang JH. Usefulness of slimmer and open-cell-design stents for endoscopic bilateral stenting and endoscopic revision in patients with hilar cholangiocarcinoma (with video). Gastrointest Endosc. 2009;70:1109-15.
Bae JI, Park AW, Choi SJ, Kim HP, Lee SJ, Park YM. Crisscross-configured dual stent placement for trisectoral drainage in patients with advanced biliary hilar malignancies. J Vasc Interv Radiol. 2008;19:1614-9.
Naitoh I, Ohara H, Nakazawa T, Ando T, Hayashi K, Okumura F. Unilateral versus bilateral endoscopic metal stenting for malignant hilar biliary obstruction. J Gastroenterol Hepatol. 2009;24:552-7.
Inal M, Akgül E, Aksungur E, Seydaoğlu G. Percutaneous placement of biliary metallic stents in patients with malignant hilar obstruction: unilobar versus bilobar drainage. J Vasc Interv Radiol. 2003;14:1409-16.
Gwon DI, Ko GY, Sung KB, Yoon HK, Shin JH, Kim HJ. Percutaneous biliary metallic stent placement in patients with unilobar portal vein occlusion caused by advanced hilar malignancy: outcome of unilateral versus bilateral stenting. AJR Am J Roentgenol. 2011;197:795-801.
Chang WH, Kortan P, Haber GB. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc. 1998;47:354-62.
Cowling MG, Adam AN. Internal stenting in malignant biliary obstruction. World J Surg. 2001;25:355-9.
De Palma GD, Galloro G, Siciliano S, Iovino P, Catanzano C. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc. 2001;53:547-53.
Polydorou AA, Cairns SR, Dowsett JF, Hatfield AR, Salmon PR, Cotton PB. Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion. Gut. 1991;32:685-9.
Lee TH, Moon JH, Park SH. Bilateral metallic stenting in malignant hilar obstruction. Clin Endosc. 2014;47:440-6.
Dowsett JF, Vaira D, Hatfield AR, Cairns SR, Polydorou A, Frost R. Endoscopic biliary therapy using the combined percutaneous and endoscopic technique. Gastroenterology. 1989;96:1180-6.
Sherman S. Endoscopic drainage of malignant hilar obstruction: is one biliary stent enough or should we work to place two?. Gastrointest Endosc. 2001;53:681-4.
Brountzos EN, Ptochis N, Panagiotou I, Malagari K, Tzavara C, Kelekis D. A survival analysis of patients with malignant biliary strictures treated by percutaneous metallic stenting. Cardiovasc Intervent Radiol. 2007;30:66-73.
Gwon DI, Ko GY, Kim JH, Shin JH, Kim KA, Yoon HK. Percutaneous bilateral metallic stent placement using a stentin-stent deployment technique in patients with malignant hilar biliary obstruction. AJR Am J Roentgenol. 2013;200:909-14.
LaBerge JM, Doherty M, Gordon RL, Ring EJ. Hilar malignancy: treatment with an expandable metallic transhepatic biliary stent. Radiology. 1990;177:793-7.
Kubota Y, Nakatani S, Nakahashi Y, Takaoka M, Kin H, Inoue K. Bilateral internal biliary drainage of hilar cholangiocarcinoma with modified Gianturco Z stents inserted via a single percutaneous tract. J Vasc Interv Radiol. 1993;4:605-10.
Gwon DI, Ko GY, Yoon HK, Kim YJ, Kim TH, Lee WH. Safety and efficacy of percutaneous Y-configured covered stent placement for malignant hilar biliary obstruction: a prospective, pilot study. J Vasc Interv Radiol. 2012;23:528-34.
Ahn SJ, Bae JI, Han TS, Won JH, Kim JD, Kwack KS. Percutaneous biliary drainage using open cell stents for malignant biliary hilar obstruction. Korean J Radiol. 2012;13:795-802.
Gwon DI, Ko GY, Yoon HK, Kim JH, Lee JM, Ohm JY. Prospective evaluation of a newly designed T-configured stent graft system for palliative treatment of advanced hilar malignant biliary obstructions. J Vasc Interv Radiol. 2010;21:1410-8.
van Delden OM, Laméris JS. Percutaneous drainage and stenting for palliation of malignant bile duct obstruction. Eur Radiol. 2008;18:448-56.
Gwon DI, Laasch HU. Radiological approach to benign biliary strictures. Gastrointest Interv. 2015;4:9-14.
Pomerantz BJ. Biliary tract interventions. Tech Vasc Interv Radiol. 2009;12:162-70.
Freeman ML, Overby C. Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents. Gastrointest Endosc. 2003;58:41-9.
Saad WE, Wallace MJ, Wojak JC, Kundu S, Cardella JF. Quality improvement guidelines for percutaneous transhepatic cholangiography, biliary drainage, and percutaneous cholecystostomy. J Vasc Interv Radiol. 2010;21:789-95.
Morgan RA, Adam AN. Malignant biliary disease: percutaneous interventions. Tech Vasc Interv Radiol. 2001;4:147-52.
Sato Y, Inaba Y, Murata S, Yamaura H, Kato M, Kawada H. Percutaneous drainage for afferent limb syndrome and pancreatic fistula via the blind end of the jejunal limb after pancreatoduodenectomy or bile duct resection. J Vasc Interv Radiol. 2015;26:566-72.
Kim YH, Han JK, Lee KH, Kim TK, Kim KW, Choi BI. Palliative percutaneous tube enterostomy in afferent-loop syndrome presenting as jaundice: clinical effectiveness. J Vasc Interv Radiol. 2002;13:845-9.
Mukai T, Yasuda I, Isayama H, Nakashima M, Doi S, Iwashita T. Comparison of axial force and cell width of self-expandable metallic stents: which type of stent is better suited for hilar biliary strictures?. J Hepatobiliary Pancreat Sci. 2011;18:646-52.
Tiewala MA, Freeman ML. Self-expanding metallic stents for malignant hilar biliary obstruction. Self-expandable stents in the gastrointestinal tract, Kozarek RA, Baron TH, Song HY, editors. New York: Springer Science+Business Media; 2013, p. 217-33
Saito H, Hokotate H, Takeuchi S. Interventional therapy using percutaneous transhepatic route for biliary diseases. Nichidoku-Iho. 2007;52:41-53.
Winick AB, Waybill PN, Venbrux AC. Complications of percutaneous transhepatic biliary interventions. Tech Vasc Interv Radiol. 2001;4:200-6.
Ridtitid W, Rerknimitr R, Janchai A, Kongkam P, Treeprasertsuk S, Kullavanijaya P. Outcome of second interventions for occluded metallic stents in patients with malignant biliary obstruction. Surg Endosc. 2010;24:2216-20.
Bueno JT, Gerdes H, Kurtz RC. Endoscopic management of occluded biliary Wall-stents: a cancer center experience. Gastrointest Endosc. 2003;58:879-84.
Hara K, Yamao K, Niwa Y, Sawaki A, Mizuno N, Hijioka S. Prospective clinical study of EUS-guided choledochoduodenostomy for malignant lower biliary tract obstruction. Am J Gastroenterol. 2011;106:1239-45.
Gupta R, Reddy DN. Endoscopic stent placement combined with tumor ablation therapy. Gastrointest Interv. 2015;4:27-30.
Strand DS, Cosgrove ND, Patrie JT, Cox DG, Bauer TW, Adams RB. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma. Gastrointest Endosc. 2014;80:794-804.
Wu TT, Li HC, Li WM, Ao GK, Lin H, Zheng F. Percutaneous intraluminal radiofrequency ablation for malignant extrahepatic biliary obstruction: a safe and feasible method. Dig Dis Sci. 2015;60:2158-63.
Mizandari M, Pai M, Xi F, Valek V, Tomas A, Quaretti P. Percutaneous intraductal radiofrequency ablation is a safe treatment for malignant biliary obstruction: feasibility and early results. Cardiovasc Intervent Radiol. 2013;36:814-9.
Krokidis M, Hatzidakis A. Percutaneous minimally invasive treatment of malignant biliary strictures: current status. Cardiovasc Intervent Radiol. 2014;37:316-23.